...
首页> 外文期刊>European journal of pharmaceutical sciences >Investigation of novel supersaturating drug delivery systems of chlorthalidone: The use of polymer-surfactant complex as an effective carrier in solid dispersions
【24h】

Investigation of novel supersaturating drug delivery systems of chlorthalidone: The use of polymer-surfactant complex as an effective carrier in solid dispersions

机译:ChlorthalidOne的新型超饱和药物递送系统的研究:使用聚合物 - 表面活性剂复合物作为固体分散体中的有效载体的用途

获取原文
获取原文并翻译 | 示例

摘要

Supersaturating drug delivery systems (SDDS), as solid dispersions (SDs), stand out among strategies to enhance bioavailability of poorly soluble drugs. After oral administration, their dissolution in gastrointestinal fluids often leads to supersaturation, which drives to a rapid and sustained absorption. Polymers and surfactants play important roles in SDs through inhibiting precipitation caused by transitions from amorphous into crystalline form, in supersaturated solutions, and also through improving SDs physical stability. Novel chlorthalidone SDs, a BCS IV drug, were developed using polymeric and non-polymeric carriers, specially a polymer-surfactant complex. SDs drug releases were evaluated using sink and non-sink conditions in water and biorelevant medium. Their physical stability was also monitored under different storage conditions. Polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer (SOL), sodium lauryl sulfate (SLS) and a combination of both showed promising results in apparent solubility studies, and therefore they were selected to compose the spray dried SDs. Dissolution studies demonstrated the SOL-SLS complex potential for providing chlorthalidone fast release (> 80% in 15 min), producing and maintaining in vitro supersaturation. This formulation comprising high drug loading (75%) reached a high supersaturation degree under non-sink condition (up to 6-fold the equilibrium solubility) once maintained for 6 h in biorelevant medium. In addition, this SD presented better physical stability when compared to the chlorthalidone neat amorphous. The SOL-SLS complex impacts positively on chlorthalidone release and physical stability, highlighting its potential as carrier in SDDS of a poorly soluble drug.
机译:作为固体分散体(SDS)的超饱和药物递送系统(SDD),突出策略,以提高可溶性药物不良的生物利用度。口服施用后,它们在胃肠液中的溶解通常导致过饱和,驱动到快速和持续的吸收。聚合物和表面活性剂在SDS中发挥重要作用,通过抑制由非晶的转变为结晶形式,在超饱和溶液中引起的沉淀,以及通过改善SDS物理稳定性。使用聚合物和非聚合物载体,特别是聚合物表面活性剂复合物,开发了一种新的Chlorthalthone SDS,BCS IV药物。使用水和生物和生物拉伸介质中的水槽和非水槽条件评估SDS药物释放。在不同的储存条件下也监测它们的物理稳定性。聚乙烯醇己内酰胺 - 聚乙烯醇 - 聚乙二醇接枝共聚物(溶胶),十二烷基硫酸钠(SLS)和两者的组合显示出明显的溶解度研究的有希望的结果,因此选择它们以构成喷雾干燥的SDS。溶出研究证明了溶胶-SLS提供了用于提供ChlorthalidOne快速释放(15分钟内> 80%)的溶胶 - SLS复合电位,生产和维持体外过饱和。该制剂包含高药物负载(75%)在非水槽条件下达到高饱和度(高达6倍的平衡溶解度),一旦在Biorelevant介质中保持6小时。此外,与Chlorthalthaldone整洁无定形相比,该SD呈现出更好的物理稳定性。溶胶-SLS复杂地对Chlorthaltalone释放和物理稳定性积极影响,突出其作为载体在可溶性药物的SDD中的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号